MAPT and Alzheimer disease: This systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure a transparent and comprehensive synthesis of the literature on blood biomarkers β-amyloid (Aβ) and phosphorylated tau (p-Tau) in the early diagnosis of AD.